{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:40:57Z","timestamp":1760899257417,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.tjog.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T21:33:41Z","timestamp":1450128821000},"page":"766-772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Significance of adding progesterone to the Risk of Ovarian Malignancy Algorithm for early stage ovarian cancer detection in patients with a pelvic mass: A single-center case\u2013control study"],"prefix":"10.1016","volume":"54","author":[{"given":"Kazimierz","family":"Pitynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Sporek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iga","family":"Lipinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Banas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Ludwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ba\u0142ajewicz-Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2015.10.006_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tjog.2013.08.002","article-title":"Perioperative blindness after debulking surgery for ovarian cancer","volume":"53","author":"Chang","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2015.10.006_bib2","article-title":"The prospective external validation of International Ovarian Tumor Analysis (IOTA) simple rules in the hands of level I and II examiners","author":"Knafel","year":"2015","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.tjog.2015.10.006_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tjog.2014.05.002","article-title":"The Risk of Malignancy Index (RMI) in women with adnexal masses in Wales","volume":"53","author":"Abdulrahman","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2015.10.006_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jmri.23721","article-title":"MRI of ovarian masses","volume":"37","author":"Vargas","year":"2013","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.tjog.2015.10.006_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tjog.2013.10.041","article-title":"Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings","volume":"53","author":"Kim","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2015.10.006_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A\u00a0radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tjog.2015.10.006_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ijgc-00009577-200511001-00015","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.tjog.2015.10.006_bib8","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/1055-9965.EPI-12-0616","article-title":"Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer","volume":"21","author":"Urban","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.tjog.2015.10.006_bib9","first-page":"815","article-title":"Diagnosis and management of adnexal masses","volume":"80","author":"Givens","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.tjog.2015.10.006_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tjog.2012.01.025","article-title":"Dramatic changes of CA 125 levels in a pregnant woman with a degenerated subserosal myoma","volume":"51","author":"Cho","year":"2012","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2015.10.006_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejogrb.2011.05.021","article-title":"Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer","volume":"158","author":"Paek","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tjog.2015.10.006_bib12","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstr\u00f6m","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.tjog.2015.10.006_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/17530059.2011.559459","article-title":"Two novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma","volume":"5","author":"Hellstrom","year":"2011","journal-title":"Expert Opin Med Diagn"},{"key":"10.1016\/j.tjog.2015.10.006_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/IGC.0b013e318234f852","article-title":"The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis","volume":"22","author":"Kadija","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.tjog.2015.10.006_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review","volume":"66","author":"Ferraro","year":"2013","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.tjog.2015.10.006_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2014.11.015","article-title":"ROMA, an algorithm for ovarian cancer","volume":"440","author":"Chudecka-G\u0142az","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.tjog.2015.10.006_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A\u00a0novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2015.10.006_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the Risk of Ovarian Malignancy Algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tjog.2015.10.006_bib19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.clinbiochem.2011.04.011","article-title":"Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases","volume":"44","author":"Park","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.tjog.2015.10.006_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2009.10.087","article-title":"Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer","volume":"116","author":"Andersen","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2015.10.006_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2011.06.033","article-title":"Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin\/paclitaxel chemotherapy: a single institution experience","volume":"123","author":"Bamias","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2015.10.006_bib22","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4161\/cc.25070","article-title":"Progesterone and FOXO1 signaling: harnessing cellular senescence for the treatment of ovarian cancer","volume":"12","author":"Brosens","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tjog.2015.10.006_bib23","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4161\/cc.25072","article-title":"Progestins: pro-senescence therapy for ovarian cancer?","volume":"12","author":"Oesterreich","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tjog.2015.10.006_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/IGC.0000000000000316","article-title":"International Federation of Gynecology and Obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer","volume":"25","author":"Pereira","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.tjog.2015.10.006_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jnci\/djj019","article-title":"Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients","volume":"98","author":"Earle","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.tjog.2015.10.006_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2005.06.040","article-title":"Potential markers that complement expression of CA125 in epithelial ovarian cancer","volume":"99","author":"Rosen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2015.10.006_bib27","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.tjog.2015.10.006_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2013.03.001","article-title":"Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age","volume":"129","author":"Kondalsamy-Chennakesavan","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2015.10.006_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2407-12-258","article-title":"Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis","volume":"12","author":"Li","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tjog.2015.10.006_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejogrb.2012.10.036","article-title":"Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis","volume":"167","author":"Lin","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tjog.2015.10.006_bib31","first-page":"49","article-title":"Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC Consortium","volume":"7","author":"Braicu","year":"2014","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.tjog.2015.10.006_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2014.07.040","article-title":"Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders","volume":"438","author":"Kappelmayer","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.tjog.2015.10.006_bib33","first-page":"45","article-title":"The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors","volume":"6","author":"\u0141awicki","year":"2013","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.tjog.2015.10.006_bib34","first-page":"44","article-title":"The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer","volume":"6","author":"Anastasi","year":"2013","journal-title":"J\u00a0Ovarian Res"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455915002387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455915002387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:14:27Z","timestamp":1760897667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455915002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1028455915002387"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2015.10.006","relation":{},"ISSN":["1028-4559"],"issn-type":[{"type":"print","value":"1028-4559"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of adding progesterone to the Risk of Ovarian Malignancy Algorithm for early stage ovarian cancer detection in patients with a pelvic mass: A single-center case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}